Bhatta Subash, Sharma Dibya, Sharma Santosh, Maharjan Leison, Bhattachan Sushma, Shah Mukesh Kumar, Singhal Aditya, Ghanpur Asheesh Dora, Ganesuni Dushyanth, Saindani Shraddha Jayant
Indira Gandhi Memorial Hospital, Male', Maldives.
Devdaha Medical College, Butwal, Nepal.
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2978-2984. doi: 10.1007/s12070-021-02664-z. Epub 2021 May 28.
To study the incidence of the smell and taste disturbance in the COVID-19 patients and a follow up at 4 months to observe for the duration of resolution of these symptoms. This is a multicentric prospective study carried out in 3 different countries, from April, 2020 to January, 2021. The COVID-19 positive patients, aged between 15 and 60 years, were inquired about the presence of any smell or taste related symptoms. The same patients were followed up with the telephonic interview after 2 months and then after 4 months, respectively. The duration of resolution of the smell and taste disturbance symptoms was noted. Total of 188 COVID-19 positive patients, average age 33.1 ± 1.7 years, 54.2% males and 45.8% female were included in the study. The smell disturbance was present in 60.6% (hyposmia 36.1%, anosmia 20.2%, and parosmia 4.2%) and taste disturbance in 28.7% of patients (hypogeusia 20.2%, ageusia 6.9%, and parageusia 1.6%). There was improvement of anosmia by 97.4, hyposmia by 95.6%, parosmia by 100%, ageusia by 100%, hypogeusia 94.8%, and parageusia by 66.7%, at 4 months follow up. The present study concludes that the smell and taste disturbances are one of the main early presenting features of the COVID-19 infection. The temporary effect of the COVID-19 infection on the olfactory and gustatory pathway was also highlighted with more than 95% patients improving at 4 months of follow up.
研究新冠病毒疾病(COVID-19)患者嗅觉和味觉障碍的发生率,并在4个月时进行随访,观察这些症状的缓解持续时间。这是一项于2020年4月至2021年1月在3个不同国家开展的多中心前瞻性研究。对年龄在15至60岁之间的COVID-19阳性患者询问是否存在任何与嗅觉或味觉相关的症状。分别在2个月和4个月后通过电话访谈对同一批患者进行随访。记录嗅觉和味觉障碍症状的缓解持续时间。共有188例COVID-19阳性患者纳入研究,平均年龄33.1±1.7岁,男性占54.2%,女性占45.8%。60.6%的患者存在嗅觉障碍(嗅觉减退36.1%,嗅觉丧失20.2%,嗅觉异常4.2%),28.7%的患者存在味觉障碍(味觉减退20.2%,味觉丧失6.9%,味觉异常1.6%)。在4个月随访时,嗅觉丧失改善了97.4%,嗅觉减退改善了95.6%,嗅觉异常改善了100%,味觉丧失改善了100%,味觉减退改善了94.8%,味觉异常改善了66.7%。本研究得出结论,嗅觉和味觉障碍是COVID-19感染的主要早期表现特征之一。COVID-19感染对嗅觉和味觉通路的暂时影响也得到凸显,超过95%的患者在4个月随访时症状有所改善。